On the nature of the adrenergic neuron extragranular amine binding site.
D000547:Amantadine / Q000494:pharmacology*; D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D001665:Binding Sites / Q000187:drug effects*; D001679:Biogenic Amines / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism; D005260:Female; D006145:Guanethidine / Q000494:pharmacology; D006834:Hydrazines / Q000494:pharmacology; D006892:Hydroxydopamines / Q000494:pharmacology; D009206:Myocardium / Q000378:metabolism*; D009638:Norepinephrine / Q000378:metabolism; D009647:Normetanephrine / Q000494:pharmacology; D009655:Octopamine / Q000378:metabolism; D010643:Phenoxybenzamine / Q000494:pharmacology; D051381:Rats; D011941:Receptors, Adrenergic / Q000187:drug effects*; D012110:Reserpine / Q000494:pharmacology; D013747:Tetrabenazine / Q000494:pharmacology; D014316:Tritium; D014439:Tyramine / Q000378:metabolism
D001679:Biogenic Amines; D006834:Hydrazines; D006892:Hydroxydopamines; D011941:Receptors, Adrenergic; D009647:Normetanephrine; D010643:Phenoxybenzamine; D014316:Tritium; D009655:Octopamine; D012110:Reserpine; D000547:Amantadine; D000661:Amphetamine; D004298:Dopamine; D009638:Norepinephrine; D014439:Tyramine; D013747:Tetrabenazine; D006145:Guanethidine